Literature DB >> 3416969

On the disposition of intrahippocampally injected kynurenic acid in the rat.

W A Turski1, R Schwarcz.   

Abstract

The disposition of kynurenic acid (KYNA), a tryptophan metabolite and broad spectrum antagonist at excitatory amino acid receptors, was studied following the unilateral intrahippocampal injection of 3H-KYNA in the rat. KYNA was rapidly cleared from the injected hippocampus. Similar decay curves were observed in several brain regions ipsi- and contralateral to the injection site as well as in serum and renal tissue. The radioactivity retained in tissue or excreted in urine for the first two hours after a 3H-KYNA injection was identified as unmetabolized KYNA. Moreover, direct measurement in hippocampal slices failed to provide evidence for the presence of specific cellular uptake mechanisms for KYNA. The present results do not support a neurotransmitter function for KYNA in the rat brain. However, they do not rule out a role of KYNA in the pathogenesis of neurodegenerative and seizure disorders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416969     DOI: 10.1007/BF00248748

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  10 in total

1.  The conversion of kynurenic acid to quinaldic acid by humans and rats.

Authors:  M KAIHARA; J M PRICE; H TAKAHASHI
Journal:  J Biol Chem       Date:  1956-12       Impact factor: 5.157

2.  Kynurenine pyruvate transaminase in rat brain.

Authors:  Y Minatogawa; T Noguchi; R Kido
Journal:  J Neurochem       Date:  1974-07       Impact factor: 5.372

3.  Muscle relaxant action of excitatory amino acid antagonists.

Authors:  L Turski; M Schwarz; W A Turski; T Klockgether; K H Sontag; J F Collins
Journal:  Neurosci Lett       Date:  1985-02-04       Impact factor: 3.046

4.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

5.  Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate- or kainate-receptors.

Authors:  P L Herrling
Journal:  Neuroscience       Date:  1985-02       Impact factor: 3.590

6.  Purification and characterization of kynurenine--2-oxoglutarate aminotransferase from the liver, brain and small intestine of rats.

Authors:  T Noguchi; Y Minatogawa; E Okuno; M Nakatani; M Morimoto
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

7.  Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?

Authors:  L Turski; B S Meldrum; J F Collins
Journal:  Brain Res       Date:  1985-06-10       Impact factor: 3.252

8.  Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.

Authors:  A C Foster; L P Miller; W H Oldendorf; R Schwarcz
Journal:  Exp Neurol       Date:  1984-05       Impact factor: 5.330

9.  Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid.

Authors:  A C Foster; A Vezzani; E D French; R Schwarcz
Journal:  Neurosci Lett       Date:  1984-08-10       Impact factor: 3.046

10.  Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord.

Authors:  A H Ganong; T H Lanthorn; C W Cotman
Journal:  Brain Res       Date:  1983-08-22       Impact factor: 3.252

  10 in total
  14 in total

1.  Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.

Authors:  Manickavasagom Alkondon; Edna F R Pereira; Howard M Eisenberg; Yasushi Kajii; Robert Schwarcz; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2011-01-26       Impact factor: 4.030

Review 2.  Kynurenic acid as an antagonist of α7 nicotinic acetylcholine receptors in the brain: facts and challenges.

Authors:  Edson X Albuquerque; Robert Schwarcz
Journal:  Biochem Pharmacol       Date:  2012-12-25       Impact factor: 5.858

3.  L-alpha-aminoadipate inhibits kynurenate synthesis in rat brain hippocampus and tissue culture.

Authors:  Y F Chang; R K Cauley; J D Chang; V V Rao
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

Review 4.  Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders.

Authors:  Sophie Erhardt; Sara K Olsson; Göran Engberg
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

5.  Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.

Authors:  Ping Yu; Nicholas A Di Prospero; Michael T Sapko; Tao Cai; Amy Chen; Miguel Melendez-Ferro; Fu Du; William O Whetsell; Paolo Guidetti; Robert Schwarcz; Danilo A Tagle
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.

Authors:  T Zarnowski; M Bialek; R Rejdak; E Zrenner; A Junemann; Z Zagorski; T Kocki; W A Turski
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

7.  Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.

Authors:  Zuzana Justinova; Paola Mascia; Hui-Qiu Wu; Maria E Secci; Godfrey H Redhi; Leigh V Panlilio; Maria Scherma; Chanel Barnes; Alexandra Parashos; Tamara Zara; Walter Fratta; Marcello Solinas; Marco Pistis; Jack Bergman; Brian D Kangas; Sergi Ferré; Gianluigi Tanda; Robert Schwarcz; Steven R Goldberg
Journal:  Nat Neurosci       Date:  2013-10-13       Impact factor: 24.884

8.  Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.

Authors:  Gáspár Oláh; Judit Herédi; Akos Menyhárt; Zsolt Czinege; Dávid Nagy; János Fuzik; Kitti Kocsis; Levente Knapp; Erika Krucsó; Levente Gellért; Zsolt Kis; Tamás Farkas; Ferenc Fülöp; Arpád Párdutz; János Tajti; László Vécsei; József Toldi
Journal:  Drug Des Devel Ther       Date:  2013-09-16       Impact factor: 4.162

9.  Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord.

Authors:  Wojciech Dabrowski; Jacek M Kwiecien; Radoslaw Rola; Michal Klapec; Greg J Stanisz; Edyta Kotlinska-Hasiec; Wendy Oakden; Rafal Janik; Margaret Coote; Benicio N Frey; Waldemar A Turski
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

10.  Sex Differences in Hippocampal Memory and Kynurenic Acid Formation Following Acute Sleep Deprivation in Rats.

Authors:  Annalisa M Baratta; Silas A Buck; Austin D Buchla; Carly B Fabian; Shuo Chen; Jessica A Mong; Ana Pocivavsek
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.